No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
Cantor Fitzgerald Initiates Voyager Therapeutics(VYGR.US) With Buy Rating
Voyager Therapeutics Price Target Announced at $5.73/Share by Cantor Fitzgerald
Cantor Fitzgerald Initiates Voyager Therapeutics at Overweight
Solid Biosciences Stock Jumps 11% Post-market on FDA Update
Voyager Therapeutics, Inc. (VYGR): Is This Gene Therapy Stock a Good Buy Right Now?
Institutional Investors Own a Significant Stake of 48% in Voyager Therapeutics, Inc. (NASDAQ:VYGR)